Background The Mini Mental State Examination (MMSE) is a cognitive test that is commonly
used as part of the evaluation for possible dementia. Objectives To determine the diagnostic …

Background Dementia is a progressive syndrome of global cognitive impairment with
significant health and social care costs. Global prevalence is projected to increase …

The optimal management of post-stroke cognitive impairment remains controversial. These
joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) …

Objective The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) is a
cognitive screening tool that aims to differentiate healthy cognitive aging from Mild Cognitive …

Incomplete reporting has been identified as a major source of avoidable waste in biomedical
research. Essential information is often not provided in study reports, impeding the …

Importance Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are
underrepresented in studies of AD biomarkers, including amyloid positron emission …

Importance Blood biomarkers able to diagnose Alzheimer disease (AD) at the preclinical
stage would enable trial enrollment when the disease is potentially reversible. Plasma …

The close relationship between stroke and dementia is an important health issue. Ischaemic
stroke can facilitate the onset of vascular dementia as well as aggravate pre‐existing …

Background Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic
predementia phase of Alzheimer's disease dementia, characterised by cognitive and …

Memory loss in Alzheimer's disease (AD) is attributed to pervasive weakening and loss of
synapses. Here, we present findings supporting a special role for excitatory synapses …